Adult macaques do not develop disease after infection with a nef delet
ion mutant of the simian immunodeficiency virus (SIV) and are protecte
d against challenge with pathogenic virus. This finding led to the pro
posal to use nef-deleted viruses as live, attenuated vaccines to preve
nt human acquired immunodeficiency syndrome (AIDS). In contrast, neona
tal macaques developed persistently high levels of viremia after oral
exposure to an SIV nef, vpr, and negative regulatory element (NRE) del
etion mutant. Severe hemolytic anemia, thrombocytopenia, and CD4(+) T
cell depletion were observed, indicating that neither nef nor vpr dete
rmine pathogenicity in neonates. Because such constructs have retained
their pathogenic potential, they should not be used as candidate live
, attenuated virus vaccines against human AIDS.